Examination of E-MTAB-4321 dataset, which consisted of 476 early-stage bladder cancer, revealed that tumors exhibiting elevated IGF2BP3 levels had a higher tendency to progress to advanced T stage (p < 0.001, Fig. 2I). This evidence concerns the gene IGF2BP3 and urinary bladder carcinoma.